A case of familial hypercholesterolemia; secession from LDL-apheresis by the drug treatment with potent statin and resin

Tokai Journal of Experimental and Clinical Medicine

Volumn 30, Issue 3, 2005, Pages 149-155

  Shiina, Yutaka ^a   Homma, Yasuhiko ^b   Oguma, Toshiaki ^a   Fusegawa, Yuichi ^a   Ozawa, Hideki ^a   Handa, Shunnosuke ^b   Tanabe, Teruhisa ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Atorvastatin; Cholestimide; Familial hypercholesterolemia; Low density lipoprotein (LDL) apheresis

Indexed keywords

ATORVASTATIN; BILE ACID SEQUESTRANT; CLINOFIBRATE; COLESTILAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; PROBUCOL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DRUG POTENCY; ECONOMIC ASPECT; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOTE; HOSPITAL ADMISSION; HUMAN; MAXIMUM PERMISSIBLE DOSE; MENTAL HEALTH; OBSERVATION; OUTPATIENT DEPARTMENT; PLASMAPHERESIS; RISK ASSESSMENT; THYMOMA; TIME SERIES ANALYSIS;

ACHILLES TENDON; ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; BLOOD COMPONENT REMOVAL; CORONARY VESSELS; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, LDL; MIDDLE AGED; PEDIGREE; PYRROLES; XANTHOMATOSIS;

EID: 28244473606     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. th edition: 1981-2030, 1995.
2. Mabuchi H, et al: Homozygous Familial Hypercholesterolemia in Japan. Am J Med 65: 290-297, 1978.
3. Mabuchi H: Hokuriku FH-CHD Study Group. Development of coronary heart disease in familial hypercholesterolemia. Circulation 79: 225-232, 1989.
4. Mabuchi H, et al: A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 68: 19-25, 1987.
5. J-CLAStudy group: Efficacy of atrovastatin in primary hypercholesterolemia. Japan Cholesterol lowering Atrovastatin Study (J-CLAS) Group. Am J Cardiol 79: 1248-1252, 1997.
6. Homma Y, et al: Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hypercholestrolemia. Atherosclerosis 129: 231-248, 1997.
7. Mabuchi H, et al: Discrimination of familial hypercholesterolemia and secondary hypercholesterol emia by Achilles tendon thickness. Atherosclerosis 28: 61-68, 1977.
8. Lehtonen A, et al: Achilles tendon thickness in hypercholesterolemia. Ann Clin Res 13: 39-44, 1981.
9. Japan Atherosclerosis Society (JAS) Guidelines for Diagnosis and Treatment of Atherosclerotic Cardiovascular Diseases. 2002.
10. Nishimura S, et al: Effect of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS). Atherosclerosis 144: 409-417, 1999.
11. Thompson GR, et al: Plasma exchange in the management of homozygous familial hyperchoresterolemia. Lancet i: 1208-1211, 1975.
12. Yokoyama S, et al: Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 5: 613-622, 1985.
13. Mabuchi H, Koizumi J, Shimizu M, et al: Long-term efficacy of low-density lipoprotein apheresis and on coronary heart disease in familial hypercholesterolemia. Am J Cardiol 82: 1489-1495, 1998.
14. Kroon AA, et al: LDL-apheresis Atherosclerosis Regression Study (LAARS), Effect of aggressive versus conventional lipid lower treatment on coronary atherosclerosis. Circulation 93: 1826-1835, 1996.
15. Marais AD, et al: Atrovastatin: an effective lipid-modifying agent in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 17: 1527-1531, 1997.
16. Lipid Research Clinics Program: The lipid research clinics coronary primary prevention trial results: I. Reduction in incidence of coronary heart disease. JAMA 251: 351-364, 1981.
17. Watts GF, et al: Effect on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St thomas' Atherosclerosis Regression Study. Lancet 339: 563-569, 1992.